Indeed, in clinical samples, the presence of unmethylated SERPINB5 has demonstrated its potential as a specific biomarker for pancreatic tumors, enabling the differentiation of pancreatic ductal adenocarcinoma (PDAC) from pancreatitis [58]. Here, SERPINB5 is linked to pancreatic neoplasm.